Mirador Capital Partners’s Kailera Therapeutics KLRA Stock Holding History

Mirador Capital Partners’s Portfolio KLRA Stock Details KLRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$666K	Buy	+58,284	New	+$985K	0.08%	137

Other funds holding KLRA

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Mirador Capital Partners's KLRA Position: Q3 2026 in Review

Mirador Capital Partners opened a new position in Kailera Therapeutics (KLRA) in Q3 2026: 58,284 shares worth $666K. The stake represents 0.08% of the portfolio and ranks #137 among its holdings.

4 funds tracked by Wall St. Rank hold KLRA as of Q3 2026.

Mirador Capital Partners held 58,284 shares of Kailera Therapeutics worth $666K as of Q3 2026.
Kailera Therapeutics was a new Mirador Capital Partners position in Q3 2026.
Kailera Therapeutics made up 0.08% of Mirador Capital Partners's portfolio in Q3 2026, its #137 holding.
4 funds tracked by Wall St. Rank held Kailera Therapeutics as of Q3 2026.

Based on Mirador Capital Partners's 13F filing for Q3 2026, filed 9 Oct 2026.